APA (7th ed.) Citation

Ghazanfar, M. N., Bartko, E. A., Arildsen, N. S., Poulsen, L. K., Jensen, B. M., Enevold, C., . . . Thomsen, S. F. (2022). Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study. Clinical & Experimental Allergy, 52(5), 715. https://doi.org/10.1111/cea.14121

Chicago Style (17th ed.) Citation

Ghazanfar, Misbah Noshela, et al. "Omalizumab Serum Levels Predict Treatment Outcomes in Patients with Chronic Spontaneous Urticaria: A Three‐month Prospective Study." Clinical & Experimental Allergy 52, no. 5 (2022): 715. https://doi.org/10.1111/cea.14121.

MLA (9th ed.) Citation

Ghazanfar, Misbah Noshela, et al. "Omalizumab Serum Levels Predict Treatment Outcomes in Patients with Chronic Spontaneous Urticaria: A Three‐month Prospective Study." Clinical & Experimental Allergy, vol. 52, no. 5, 2022, p. 715, https://doi.org/10.1111/cea.14121.